Posts Categorized: MS News

The relief of diagnosis

Source Multiple Sclerosis Net: Being diagnosed with an incurable, chronic illness such as Multiple Sclerosis is never a pleasant experience. However, for many people, getting that final confirmation creates an extreme sense of relief. That sounds pretty peculiar to many people, as getting a diagnosis of Multiple Sclerosis is not an easy process. With no single test to determine… Read more »

The MS kids are alright

Source MS Trust: How your children will cope with your MS, is an ongoing concern for the majority of parents following diagnosis. Here Martin Baum, who was diagnosed with MS over 20 years ago and his son Josh, discuss how they coped and the impact it has had on them over the years. Many years ago,… Read more »

Innovative clinical research using robotic technology to improve balance & mobility for people living with MS

A ground-breaking clinical research trial is inviting people living with Multiple Sclerosis (MS) to take part in the evaluation of a balance exercise program using a robotic walking device. This trial is the only research trial in this field taking place in the UK for people diagnosed and living with MS. The trial is pioneering… Read more »

Research shows hot chocolate could help reduce fatigue

Source MS Society: We know around 90% of people with MS experience fatigue, which can severely impact their quality of life. Researchers at Oxford Brookes University looked at whether flavonoid-rich hot chocolate was able to provide a benefit to people with MS fatigue. 40 people took part in the trial – half drank a flavonoid-rich hot… Read more »

Continuous Use of Gilenya for Up to 3 Years Can Lead to 50% Drop in Annual Relapse Rates, Real-world Study Says

Source Multiple Sclerosis News Today: Multiple sclerosis (MS) patients who began treatment with Gilenya (fingolimod) and stayed with it continuously showed a more than 50 percent reduction in annual relapse rates, a real-world study following these people for up to three years found. Results were reported in the study “Real-world durability of relapse rate reduction in patients with multiple… Read more »

Brain Cells Key to Myelin Grown in Lab and Show Long-Term Survival Essential to Research, Study Reports

Source Multiple Sclerosis News Today: Stem cells tweaked in the laboratory have allowed researchers, reportedly for a first time, to generate and maintain ball-shaped cultures — called spheroids — of human brain cells in 3D that contain oligodendrocytes, the cells that produce myelin, along with neurons and the astrocytes that are essential to nerve cell health. These long-surviving… Read more »

Letter calls for ocrelizumab to be made available for people with PPMS

Source MS Trust: A letter signed by the MS Society, MS Trust, Shift MS and leading neurologists calls on NICE, NHS England and drug manufacturer Roche to make ocrelizumab available for people with primary progressive MS. Back in September, NICE announced that it would not be recommending ocrelizumab as an NHS treatment for early primary progressive MS…. Read more »

Cochrane Review of effectiveness of exercise to prevent falls

Source Independent Living: Exercise is frequently cited as a good way of helping to prevent falls, and now we have strong evidence that a programme of exercise can indeed prevent falls amongst older people living in the community. Falls are a leading cause of accidental or unintentional injury deaths worldwide. Older adults suffer the greatest number… Read more »